{
"NDC": {
"NDCCode": "42571-345-60",
"PackageDescription": "60 TABLET in 1 BOTTLE (42571-345-60) ",
"NDC11Code": "42571-0345-60",
"ProductNDC": "42571-345",
"ProductTypeName": "HUMAN PRESCRIPTION DRUG",
"ProprietaryName": "Rivaroxaban",
"ProprietaryNameSuffix": null,
"NonProprietaryName": "Rivaroxaban",
"DosageFormName": "TABLET",
"RouteName": "ORAL",
"StartMarketingDate": "20260706",
"EndMarketingDate": null,
"MarketingCategoryName": "ANDA",
"ApplicationNumber": "ANDA208334",
"LabelerName": "Micro Labs Limited",
"SubstanceName": "RIVAROXABAN",
"StrengthNumber": "2.5",
"StrengthUnit": "mg/1",
"Pharm_Classes": "Factor Xa Inhibitor [EPC], Factor Xa Inhibitors [MoA]",
"DEASchedule": null,
"Status": "Active",
"LastUpdate": "2026-09-08",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": "20271231",
"StartMarketingDatePackage": "20260706",
"EndMarketingDatePackage": null,
"SamplePackage": "N"
}
}